You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

CEFEPIME HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for cefepime hydrochloride and what is the scope of freedom to operate?

Cefepime hydrochloride is the generic ingredient in six branded drugs marketed by B Braun, Acs Dobfar, Astral, Fosun Pharma, Hospira Inc, Qilu, Sagent Pharms Inc, Baxter Hlthcare, Samson Medcl, and Allecra Theraps, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for cefepime hydrochloride. Ten suppliers are listed for this compound.

Summary for CEFEPIME HYDROCHLORIDE
Recent Clinical Trials for CEFEPIME HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Meiji Seika Pharma Co., Ltd.Phase 3
AllecraPhase 2
Linical Co., Ltd.Phase 2

See all CEFEPIME HYDROCHLORIDE clinical trials

Pharmacology for CEFEPIME HYDROCHLORIDE

US Patents and Regulatory Information for CEFEPIME HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 202268-001 Jul 30, 2012 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira Inc MAXIPIME cefepime hydrochloride INJECTABLE;INJECTION 050679-003 Jan 18, 1996 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira Inc MAXIPIME cefepime hydrochloride INJECTABLE;INJECTION 050679-002 Jan 18, 1996 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira Inc MAXIPIME cefepime hydrochloride INJECTABLE;INJECTION 050679-001 Jan 18, 1996 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Allecra Theraps EXBLIFEP cefepime hydrochloride; enmetazobactam POWDER;INTRAVENOUS 216165-001 Feb 22, 2024 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.